UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression

BMC medicine, 2016-11, Vol.14 (1), p.179, Article 179

2016

Volltextzugriff (PDF)

Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs

Gastroenterology (New York, N.Y. 1943), 2018-02, Vol.154 (3), p.500-514

2018

Volltextzugriff (PDF)

Pharmacologic treatment of GERD in adolescents: Is esophageal mucosal protection an option?

Therapeutic advances in gastroenterology, 2022, Vol.15, p.175628482211153

2022

Volltextzugriff (PDF)

S1388 Vonoprazan-based Dual Therapy and Vonoprazan-based Triple Therapy for H. pylori Eradication: A Comparison of the Available Data

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S637-S637

2021

Volltextzugriff (PDF)

Drug-Induced Small Bowel Injury: a Challenging and Often Forgotten Clinical Condition

Current gastroenterology reports, 2019-11, Vol.21 (11), p.55, Article 55

2019

Volltextzugriff (PDF)

Nonsteroidal Antiinflammatory Drug-Related Injury to the Gastrointestinal Tract: Clinical Picture, Pathogenesis, and Prevention

Gastroenterology clinics of North America, 2010-09, Vol.39 (3), p.433-464

2010

Volltextzugriff (PDF)

Management of colonic diverticular disease in the third millennium: Highlights from a symposium held during the United European Gastroenterology Week 2017

Therapeutic Advances in Gastroenterology, 2018-01, Vol.11, p.1756284818771305-1756284818771305

2018

Volltextzugriff (PDF)

Review article: do stimulant laxatives damage the gut? A critical analysis of current knowledge

Therapeutic advances in gastroenterology, 2024-01, Vol.17, p.17562848241249664

2024

Volltextzugriff (PDF)

Ageusia, gastrointestinal symptoms and marked asthenia in late December. A single case report with positive SARS-Cov2 IgG in Italy

International journal of infectious diseases, 2020-08, Vol.97, p.352-353

2020

Volltextzugriff (PDF)

A Population Pharmacokinetic Model of Vonoprazan: Evaluating the Effects of Race, Disease Status, and Other Covariates on Exposure

Journal of clinical pharmacology, 2022-06, Vol.62 (6), p.801-811

2022

Volltextzugriff (PDF)

S470 Development and Utilization of a Pharmacokinetic/Pharmacodynamic Model for Vonoprazan to Assess the Relationship Between Dose, Exposure, and pH Holding Time Ratio

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e333-e333

2022

Volltextzugriff (PDF)

Gastric cancer prevention targeted on risk assessment: Gastritis OLGA staging

Helicobacter (Cambridge, Mass.), 2019-04, Vol.24 (2), p.e12571-n/a

2019

Volltextzugriff (PDF)

S1387 A Population Pharmacokinetic Model of Vonoprazan: Evaluating the Effects of Race and Disease Status on Exposure

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S636-S637

2021

Volltextzugriff (PDF)

Myths and Misconceptions About Chronic Constipation

The American journal of gastroenterology, 2005-01, Vol.100 (1), p.232-242

2005

Volltextzugriff (PDF)

Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients

Biomedicines, 2022-07, Vol.10 (8), p.1798

2022

Volltextzugriff (PDF)

Rifaximin, a Poorly Absorbed Antibiotic: Pharmacology and Clinical Potential

Chemotherapy, 2005-01, Vol.51 (Suppl 1), p.36-66

2005

Volltextzugriff (PDF)

Pathophysiology of NSAID-Associated Intestinal Lesions in the Rat: Luminal Bacteria and Mucosal Inflammation as Targets for Prevention

Frontiers in pharmacology, 2018-11, Vol.9, p.1340-1340

2018

Volltextzugriff (PDF)

Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats

PloS one, 2014-12, Vol.9 (12), p.e116253-e116253

2014

Volltextzugriff (PDF)

Impact of crystal polymorphism on the systemic bioavailability of rifaximin, an antibiotic acting locally in the gastrointestinal tract, in healthy volunteers

Drug design, development and therapy, 2015-01, Vol.9 (default), p.1-11

2015

Volltextzugriff (PDF)

NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same?

The Journal of pharmacology and experimental therapeutics, 2014-01, Vol.348 (1), p.86-95

2014

Volltextzugriff (PDF)

Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic

Pharmacological research, 2016-02, Vol.104, p.186-196

2016

Volltextzugriff (PDF)

Tiered approach to evaluate the CYP3A victim and perpetrator drug–drug interaction potential for vonoprazan using PBPK modeling and clinical data to inform labeling

CPT: pharmacometrics and systems pharmacology, 2023-04, Vol.12 (4), p.532-544

2023

Volltextzugriff (PDF)

Combined Treatment with Polynucleotides and Hyaluronic Acid Improves Tissue Repair in Experimental Colitis

Biomedicines, 2020-10, Vol.8 (10), p.438

2020

Volltextzugriff (PDF)

Predictive Score for Advanced Colorectal Neoplasia Based on Cardiovascular and Colorectal Cancer Risk Factors

Journal of clinical medicine, 2024-05, Vol.13 (10), p.2887

2024

Volltextzugriff (PDF)

Caustic injury of the upper gastrointestinal tract: a comprehensive review

World journal of gastroenterology : WJG, 2013-07, Vol.19 (25), p.3918-3930

2013

Volltextzugriff (PDF)

1 – 25 von 277

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(261)
Mit Volltextzugriff
(215)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(136)
Life Sciences & Biomedicine
(132)
Humans
(91)
Gastroenterology & Hepatology
(67)
Gastroenterology And Hepatology
(50)
Male
(44)
Pharmacology & Pharmacy
(42)
Biological And Medical Sciences
(35)
Animals
(31)
Medical Sciences
(26)
Female
(25)
Pharmacology. Drug Treatments
(20)
Adult
(18)
Gastroenterology
(17)
Proton Pump Inhibitors
(17)
Rats
(17)
Anti-Inflammatory Agents, Non-Steroidal - Adverse Effects
(16)
Middle Aged
(16)
Proton Pump Inhibitors - Therapeutic Use
(16)
Medicine
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression

Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs

Pharmacologic treatment of GERD in adolescents: Is esophageal mucosal protection an option?

S1388 Vonoprazan-based Dual Therapy and Vonoprazan-based Triple Therapy for H. pylori Eradication: A Comparison of the Available Data

Drug-Induced Small Bowel Injury: a Challenging and Often Forgotten Clinical Condition

Nonsteroidal Antiinflammatory Drug-Related Injury to the Gastrointestinal Tract: Clinical Picture, Pathogenesis, and Prevention

Management of colonic diverticular disease in the third millennium: Highlights from a symposium held during the United European Gastroenterology Week 2017

Review article: do stimulant laxatives damage the gut? A critical analysis of current knowledge

Ageusia, gastrointestinal symptoms and marked asthenia in late December. A single case report with positive SARS-Cov2 IgG in Italy

A Population Pharmacokinetic Model of Vonoprazan: Evaluating the Effects of Race, Disease Status, and Other Covariates on Exposure

S470 Development and Utilization of a Pharmacokinetic/Pharmacodynamic Model for Vonoprazan to Assess the Relationship Between Dose, Exposure, and pH Holding Time Ratio

Gastric cancer prevention targeted on risk assessment: Gastritis OLGA staging

S1387 A Population Pharmacokinetic Model of Vonoprazan: Evaluating the Effects of Race and Disease Status on Exposure

Myths and Misconceptions About Chronic Constipation

Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients

Rifaximin, a Poorly Absorbed Antibiotic: Pharmacology and Clinical Potential

Pathophysiology of NSAID-Associated Intestinal Lesions in the Rat: Luminal Bacteria and Mucosal Inflammation as Targets for Prevention

Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats

Impact of crystal polymorphism on the systemic bioavailability of rifaximin, an antibiotic acting locally in the gastrointestinal tract, in healthy volunteers

NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same?

Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic

Tiered approach to evaluate the CYP3A victim and perpetrator drug–drug interaction potential for vonoprazan using PBPK modeling and clinical data to inform labeling

Combined Treatment with Polynucleotides and Hyaluronic Acid Improves Tissue Repair in Experimental Colitis

Predictive Score for Advanced Colorectal Neoplasia Based on Cardiovascular and Colorectal Cancer Risk Factors

Caustic injury of the upper gastrointestinal tract: a comprehensive review

Suchergebnisse filtern